Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry

Rat H-1 parvovirus (H-1PV) is in clinical development for oncolytic therapy. Here, Kulkarni et al. identify LAMC1 as a modulator of H-1PV cell attachment and entry and find that LAMC1 levels and H-1PV oncolytic activity correlate in 59 tested cancer cell lines.

Bibliographic Details
Main Authors: Amit Kulkarni, Tiago Ferreira, Clemens Bretscher, Annabel Grewenig, Nazim El-Andaloussi, Serena Bonifati, Tiina Marttila, Valérie Palissot, Jubayer A. Hossain, Francisco Azuaje, Hrvoje Miletic, Lars A. R. Ystaas, Anna Golebiewska, Simone P. Niclou, Ralf Roeth, Beate Niesler, Amélie Weiss, Laurent Brino, Antonio Marchini
Format: Article
Language:English
Published: Nature Publishing Group 2021-06-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-021-24034-7
id doaj-e9d685fa483d413282b0592f44b963bf
record_format Article
spelling doaj-e9d685fa483d413282b0592f44b963bf2021-06-27T11:11:47ZengNature Publishing GroupNature Communications2041-17232021-06-0112111810.1038/s41467-021-24034-7Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entryAmit Kulkarni0Tiago Ferreira1Clemens Bretscher2Annabel Grewenig3Nazim El-Andaloussi4Serena Bonifati5Tiina Marttila6Valérie Palissot7Jubayer A. Hossain8Francisco Azuaje9Hrvoje Miletic10Lars A. R. Ystaas11Anna Golebiewska12Simone P. Niclou13Ralf Roeth14Beate Niesler15Amélie Weiss16Laurent Brino17Antonio Marchini18Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research CenterLaboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research CenterLaboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research CenterLaboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research CenterLaboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research CenterLaboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research CenterLaboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research CenterLaboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of HealthLaboratory of Oncolytic Virus Immuno-Therapeutics, Luxembourg Institute of HealthQuantitative Biology Unit, Luxembourg Institute of HealthDepartment of Biomedicine, University of BergenDepartment of Biomedicine, University of BergenNorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of HealthNorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of HealthnCounter Core Facility, Institute of Human Genetics, University of HeidelbergnCounter Core Facility, Institute of Human Genetics, University of HeidelbergInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC)Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC)Laboratory of Oncolytic Virus Immuno-Therapeutics, German Cancer Research CenterRat H-1 parvovirus (H-1PV) is in clinical development for oncolytic therapy. Here, Kulkarni et al. identify LAMC1 as a modulator of H-1PV cell attachment and entry and find that LAMC1 levels and H-1PV oncolytic activity correlate in 59 tested cancer cell lines.https://doi.org/10.1038/s41467-021-24034-7
collection DOAJ
language English
format Article
sources DOAJ
author Amit Kulkarni
Tiago Ferreira
Clemens Bretscher
Annabel Grewenig
Nazim El-Andaloussi
Serena Bonifati
Tiina Marttila
Valérie Palissot
Jubayer A. Hossain
Francisco Azuaje
Hrvoje Miletic
Lars A. R. Ystaas
Anna Golebiewska
Simone P. Niclou
Ralf Roeth
Beate Niesler
Amélie Weiss
Laurent Brino
Antonio Marchini
spellingShingle Amit Kulkarni
Tiago Ferreira
Clemens Bretscher
Annabel Grewenig
Nazim El-Andaloussi
Serena Bonifati
Tiina Marttila
Valérie Palissot
Jubayer A. Hossain
Francisco Azuaje
Hrvoje Miletic
Lars A. R. Ystaas
Anna Golebiewska
Simone P. Niclou
Ralf Roeth
Beate Niesler
Amélie Weiss
Laurent Brino
Antonio Marchini
Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
Nature Communications
author_facet Amit Kulkarni
Tiago Ferreira
Clemens Bretscher
Annabel Grewenig
Nazim El-Andaloussi
Serena Bonifati
Tiina Marttila
Valérie Palissot
Jubayer A. Hossain
Francisco Azuaje
Hrvoje Miletic
Lars A. R. Ystaas
Anna Golebiewska
Simone P. Niclou
Ralf Roeth
Beate Niesler
Amélie Weiss
Laurent Brino
Antonio Marchini
author_sort Amit Kulkarni
title Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
title_short Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
title_full Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
title_fullStr Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
title_full_unstemmed Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
title_sort oncolytic h-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
publisher Nature Publishing Group
series Nature Communications
issn 2041-1723
publishDate 2021-06-01
description Rat H-1 parvovirus (H-1PV) is in clinical development for oncolytic therapy. Here, Kulkarni et al. identify LAMC1 as a modulator of H-1PV cell attachment and entry and find that LAMC1 levels and H-1PV oncolytic activity correlate in 59 tested cancer cell lines.
url https://doi.org/10.1038/s41467-021-24034-7
work_keys_str_mv AT amitkulkarni oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT tiagoferreira oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT clemensbretscher oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT annabelgrewenig oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT nazimelandaloussi oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT serenabonifati oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT tiinamarttila oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT valeriepalissot oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT jubayerahossain oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT franciscoazuaje oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT hrvojemiletic oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT larsarystaas oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT annagolebiewska oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT simonepniclou oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT ralfroeth oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT beateniesler oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT amelieweiss oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT laurentbrino oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
AT antoniomarchini oncolytich1parvovirusbindstosialicacidonlamininsforcellattachmentandentry
_version_ 1721358200175853568